As of September 2019, the only FDA-approved oral GLP-1 on the market has been Rybelsus (semaglutide)
In clinical trials, people lost an average of 17% of their body weight over 64 weeks, with around one in four losing 20% or more
Some GLP-1 users report low energy from eating less, while others find they have fewer crashes, perhaps because of better blood sugar regulation
Contact the listed certification body directly and confirm that the certificate is current, that it covers the company name and address provided, and that its scope includes peptide or pharmaceutical manufacturing
However, these pharmacies are more limited in scale and can make GLP-1s for only a narrow set of reasons, not routine prescriptions
Your treatment duration depends on factors such as your overall health, weight loss goals, and response to the medication